A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
A woman has been left devastated by burglars who broke into her home as her young family slept and stole her father’s ashes.
Shoppers and visitors in Manchester are being urged to donate to the "Big Change" to give practical help to homeless people.
Each window at offices in the Northern Quarter features a unique piece of artwork.